The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sangamo Therapeutics, Inc(NASDAQ:SGMO) 
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a t...
Website: http://www.sangamo.com
Founded: 1995
Full Time Employees: 354
Sector: Healthcare
Industry: Biotechnology
Sangamo Therapeutics Days Payable Outstanding ttm (DPO)
Sangamo Therapeutics Days Receivable Outstanding ttm (DSO)
Sangamo Therapeutics Days Inventory Outstanding ttm (DIO)
Sangamo Therapeutics Op Cashflow Per Share ttm
Sangamo Therapeutics Free Cashflow Per Share ttm
Sangamo Therapeutics Cash Per Share ttm
Sangamo Therapeutics P/S ratio ttm
Sangamo Therapeutics (GAAP) P/E ratio ttm
Sangamo Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.